Indication

Dandruff

Dandruff, clinically referred to as pityriasis capitis, is a common, chronic, non-inflammatory scalp condition positioned at the mildest end of the seborrheic dermatitis spectrum. Read more about Dandruff

191 drugs 83 manufacturers

Advertisement

Drugs that treat it

Common Dandruff therapies.

Showing 127–135 of 191 drugs

Filter & compare in the drug finder →Opens the drug finder with Dandruff preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Dandruff.

Dandruff, clinically referred to as pityriasis capitis, is a common, chronic, non-inflammatory scalp condition positioned at the mildest end of the seborrheic dermatitis spectrum.

It primarily affects adolescents and adults, typically emerging post-puberty in hair-bearing regions of the scalp with active sebaceous glands.

Pathophysiologically, the condition is driven by epidermal barrier dysfunction, sebaceous lipid secretion, and an individual cutaneous response to metabolites produced by commensal *Malassezia* yeasts.

These mechanisms accelerate epidermal proliferation and turnover, producing defining clinical features of diffuse, uninflamed desquamation characterized by visible white-to-gray flakes, often accompanied by mild pruritus without marked erythema.

Personalize your experience

Follow Dandruff and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it